E-cadherin: Its dysregulation in carcinogenesis and clinical implications.

@article{Wong2018EcadherinID,
  title={E-cadherin: Its dysregulation in carcinogenesis and clinical implications.},
  author={Sonia How Ming Wong and Chee-Mun Fang and Lay Hong Chuah and Chee Onn Leong and Siew Ching Ngai},
  journal={Critical reviews in oncology/hematology},
  year={2018},
  volume={121},
  pages={
          11-22
        }
}
E-cadherin is a transmembrane glycoprotein which connects epithelial cells together at adherens junctions. In normal cells, E-cadherin exerts its tumour suppressing role mainly by sequestering β-catenin from its binding to LEF (Lymphoid enhancer factor)/TCF (T cell factor) which serves the function of transcribing genes of the proliferative Wnt signaling pathway. Despite the ongoing debate on whether the loss of E-cadherin is the cause or effect of epithelial-mesenchymal transition (EMT), E… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…